EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Scorecard

What are the weighted selection criteria?

Dose Diligence research deskSection 09 · Page 5 of 15Last updated 17 Nov 2026

Use these weights for the complete access plan after the gates pass. If a manufacturer programme or wholesaler does not perform a required function, identify the clinic or another partner that will perform it and include that work in the cost and evidence assessment.

Do not award automatic full marks for a function described as not applicable when the patient journey still requires it.

CriterionWeightWeak: 1/5Acceptable: 3/5Excellent: 5/5
1. Fulfilment reliability and capacity20Shipping promises without complete order-level evidence; backlog and cancellations omitted.Defined service windows, reconciled historical data and written capacity commitments support forecast demand.Matched-cohort performance is independently checked across multiple periods; peak-load and exception tests meet the agreed stretch targets.
2. Continuity and dependency risk15A second supplier name is offered without confirmed eligibility, acceptance or capacity.Approved fallback routes, current acceptance confirmations and a documented interruption playbook.Tested fallback handles the agreed disruption scenario; shared facilities, distributors, software and other common dependencies are mapped.
3. Total cost and patient affordability20Introductory price only; payer responsibilities, later fills or fees are unclear.Matched full-period model separates clinic, patient and insurer expenditure and stays within approved limits.Quotes reconcile to invoices or test transactions; adverse scenarios remain within buyer-approved limits, with transparent repricing and replacement treatment.
4. State and cohort operational readiness10Licensed coverage is marketed as operational readiness without product acceptance or workflow testing.Every mandatory state and patient cohort has a named route, acceptance confirmation and launch owner.State/cohort tests demonstrate onboarding, delivery, payment and support; expansion dependencies have dated completion evidence.
5. Workflow, integration and reporting12Status ends at prescription submission; staff chase orders manually.Receipt, clarification, payment, dispensing, delivery and cancellation statuses are accessible; exports and exception owners are defined.Buyer-tested reconciliation, duplicate protection, outage recovery and usable exports work across all material routes.
6. Patient service and nonclinical exception handling8Patients are passed between clinic and pharmacy; charges and next steps are unclear.Named ownership, understandable communications and support targets cover routine failures.Measured service consistently meets stretch targets; language/accessibility needs and difficult scenarios are tested.
7. Contract flexibility and financial exposure10Large prepayments, unclear refunds, automatic lock-in or weak exit assistance.Approved exposure limits, defined remedies, price-change treatment and transition obligations.Executable terms materially limit stranded commitments; exit, reconciliation and transition procedures are tested and commercially usable.
8. Implementation and accountable governance5Launch depends on informal cooperation and an optimistic start date.Named owners, dependency plan, training, pilot acceptance and review cadence.A controlled rehearsal and pilot meet acceptance criteria; rollback and evidence-refresh responsibilities are demonstrated.
Total100

Why these weights? This proposed model allocates 35 points to delivery and continuity, 20 to economics, and 45 to execution, patient service and contractual control. Quality and eligibility receive no tradeable points because they remain gates.

A clinic may change the weights before opening proposals—for example, increasing integration weight during platform consolidation. Record the rationale, retain a 100-point total and apply the same version to every candidate. Do not change weights after seeing which supplier wins.

Explore the table row by row

A working view of the research

1. Fulfilment reliability and capacity

Weight
20
Weak: 1/5
Shipping promises without complete order-level evidence; backlog and cancellations omitted.
Acceptable: 3/5
Defined service windows, reconciled historical data and written capacity commitments support forecast demand.
Excellent: 5/5
Matched-cohort performance is independently checked across multiple periods; peak-load and exception tests meet the agreed stretch targets.

Sources cited on this page

    See the section’s source register for the research context.

    Section sources →